Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Excess caloric intake can lead to insulin resistance. The underlying reasons are complex but likely related to ectopic lipid deposition in nonadipose tissue. We hypothesized that the inability to appropriately expand subcutaneous adipose tissue may be an underlying reason for insulin resistance and beta cell failure. Mice lacking leptin while overexpressing adiponectin showed normalized glucose and insulin levels and dramatically improved glucose as well as positively affected serum triglyceride levels. Therefore, modestly increasing the levels of circulating full-length adiponectin completely rescued the diabetic phenotype in ob/ob mice. They displayed increased expression of PPARgamma target genes and a reduction in macrophage infiltration in adipose tissue and systemic inflammation. As a result, the transgenic mice were morbidly obese, with significantly higher levels of adipose tissue than their ob/ob littermates, leading to an interesting dichotomy of increased fat mass associated with improvement in insulin sensitivity. Based on these data, we propose that adiponectin acts as a peripheral "starvation" signal promoting the storage of triglycerides preferentially in adipose tissue. As a consequence, reduced triglyceride levels in the liver and muscle convey improved systemic insulin sensitivity. These mice therefore represent what we believe is a novel model of morbid obesity associated with an improved metabolic profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Adiponectin, for example, has been shown to induce angiogenesis in hypoxic fat pads and tumors (75,91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Experimental — accuracy not yet measuredIn the citing paper
“These results are comparable to findings in which increasing the capacity of adipose tissue (66) or the liver (67) to incorporate fatty acids into TGs does not cause insulin resistance and can actually prevent HFD-induced insulin resistance (66).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [66]
In the citing paper
“we have previously demonstrated that overexpression of adiponectin in an ob/ob background improves vascularization and expansion of the subcutaneous fat pad in particular (91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationDamiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., & Schibler, U. (2000) · Genes & Development · doi:10.1101/gad.183500 · Cited by 2,394
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Self-citationCCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
Cited by
Items 101–200 of 996
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Self-citationTransplantation of adipose tissue and stem cells: role in metabolism and disease
Tran, T. T., & Kahn, C. R. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.20 · Cited by 330
“When obese ob/ob mice, which carry a mutation in the leptin gene, are engineered to overexpress adiponectin in adipose tissue, insulin sensitivity, diacylglycerol levels and β-cell function improve, lipid clearance increases and hepatic steatosis is reduced, despite a massive further increase in subcutaneous adipose t…”
BackgroundSarjeant, K., & Stephens, J. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008417 · Cited by 328
“Mice that are very obese but have unlimited adipose tissue expansion are metabolically healthy and insulin sensitive (Kim et al. 2007).”
du Plessis, J., van Pelt, J., Korf, H., Mathieu, C., van der Schueren, B., Lannoo, M., Oyen, T., Topal, B., Fetter, G., Nayler, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.044 · Cited by 325
“In this model, the improved metabolic profile correlated with a reduced influx in macrophage numbers.(9) In mice fed a high-fat diet, macrophage activation and proinflammatory gene expression preceded the development of inflammation in the liver.”
BackgroundCao, Y. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.008 · Cited by 319
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Chen, Z., Yu, R., Xiong, Y., Du, F., & Zhu, S. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0572-9 · Cited by 316
“Chronic overexpression of adiponectin results in increased subcutaneous fat and protects against diet-induced IR [48].”
Adipokines and the Peripheral and Neural Control of Energy Balance
Ahima, R. S., & Lazar, M. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0529 · Cited by 315
The impact of aging on adipose function and adipokine synthesis
Mancuso, P., & Bouchard, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00137 · Cited by 314
“Adiponectin promotes adipogenesis and the expansion of adipose tissue via hyperplasia, a mechanism of fat pad expansion that reduces adipose tissue inflammation and maintains insulin responsiveness and glucose homeostasis (117).”
BackgroundIt's Not How Fat You Are, It's What You Do with It That Counts
Virtue, S., & Vidal-Puig, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060237 · Cited by 312
“Despite having a body weight that is 50% greater than an ob/ob mouse, the AdTG-ob/ob mouse remains insulin-sensitive with no ectopic deposition of fat in liver [13].”
BackgroundInfluentialLi, M., Kim, D. H., Tsenovoy, P. L., Peterson, S. J., Rezzani, R., Rodella, L. F., Aronow, W. S., Ikehara, S., & Abraham, N. G. (2008) · Diabetes · doi:10.2337/db07-1764 · Cited by 311
“While increases in obesity are considered a risk factor for cardiovascular complications (37), obesityassociated improvement in the diabetic phenotype, including increases in insulin sensitivity and glucose tolerance, may occur through adipose tissue and increased adiponectin secretion (10,42).”
BackgroundResultInfluentialHigh Adiponectin Concentrations Are Associated with the Metabolically Healthy Obese Phenotype
Aguilar-Salinas, C. A., García, E. G., Robles, L., Riaño, D., Ruiz-Gomez, D. G., García-Ulloa, A. C., Melgarejo, M. A., Zamora, M., Guillen-Pineda, L. E., Mehta, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2724 · Cited by 310
Diabetes and apoptosis: lipotoxicity
Kusminski, C. M., Shetty, S., Orci, L., Unger, R. H., & Scherer, P. E. (2009) · Apoptosis · doi:10.1007/s10495-009-0352-8 · Cited by 302
“starvation signal released by the adipocyte, providing systemic indication that adipocytes can accommodate more lipids to expand stores in adipose tissue [22].”
BackgroundMethodInfluentialSelf-citationAdipose Vascular Endothelial Growth Factor Regulates Metabolic Homeostasis through Angiogenesis
Sung, H.-K., Doh, K.-O., Son, J. E., Park, J. G., Bae, Y., Choi, S., Nelson, S. M. L., Cowling, R., Nagy, K., Michael, I. P., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.010 · Cited by 303
“The ectopic fat is likely to cause lipotoxicity in the liver and muscles, contributing to the development of insulin resistance (Kim et al., 2007; Savage, 2009; Virtue and Vidal-Puig, 2010).”
BackgroundIrisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
Arhire, L. I., Mihalache, L., & Covasa, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00524 · Cited by 303
“For example, the overexpression of 11β-hydroxysteroid dehydrogenase type 1 (11-β HSD-1) in the adipose tissue of transgenic mice leads to metabolically unhealthy obesity with insulin resistance (IR) and alteration in glucose and lipid metabolism, while those overexpressing adiponectin or mitoNEET, a key regulator of m…”
BackgroundThe Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
Cusi, K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0122-6 · Cited by 300
“Overexpression of adiponectin in ob/ob mice rescues rodents from developing diabetes at the expense of morbid obesity, offering an interesting paradox of how adipocytes may adapt successfully and store pathologic amounts of fat while remaining insulin sensitive and free of diabetes [ 35 ].”
BackgroundHarford, K. A., Reynolds, C. M., McGillicuddy, F. C., & Roche, H. M. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000565 · Cited by 299
AMPK as a mediator of hormonal signalling
Lim, C. T., Kola, B., & Korbonits, M. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0063 · Cited by 298
“Adiponectin-transgenic ob/ob mice, which have serum adiponectin levels two- to threefold higher than ob/ob mice, have significantly higher body weight, but an improved metabolic state compared with ob/ob mice (Kim et al. 2007).”
BackgroundChokshi, A., Drosatos, K., Cheema, F. H., Ji, R., Khawaja, T., Yu, S., Kato, T., Khan, R., Takayama, H., Knöll, R., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.060889 · Cited by 296
Savard, C., Tartaglione, E. V., Kuver, R., Haigh, G. W., Farrell, G. C., Subramanian, S., Chait, A., Yeh, M. M., Quinn, L. S., & Ioannou, G. N. (2013) · Hepatology · doi:10.1002/hep.25789 · Cited by 295
“Adiponectin regulates whole-body lipid partitioning, providing signals that convey TGs to adipose tissue, thus sparing the liver, as well as other sites, of ectopic fat deposition.(15) Furthermore, adiponectin reduces inflammation, stimulating the secretion of anti-inflammatory cytokines (e.”
BackgroundAPPL1: role in adiponectin signaling and beyond
Deepa, S. S., & Dong, L. Q. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90731.2008 · Cited by 287
Adiponectin and cardiovascular health: an update
Hui, X., Lam, K. S., Vanhoutte, P. M., & Xu, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01395.x · Cited by 286
“In ob/ob obese mice with transgenic expression of adiponectin, the degree of macrophage infiltration in adipose tissue and systemic inflammation is markedly attenuated in comparison with wild-type obese mice, in spite of a marked expansion of adipose tissue (Kim et al., 2007).”
BackgroundFlachs, P., Rossmeisl, M., Bryhn, M., & Kopecky, J. (2009) · Clinical Science · doi:10.1042/cs20070456 · Cited by 286
Leptin and brain–adipose crosstalks
Caron, A., Lee, S., Elmquist, J. K., & Gautron, L. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.7 · Cited by 284
Joe, A. W. B., Yi, L., Even, Y., Vogl, A. W., & Rossi, F. M. V. (2009) · Stem Cells · doi:10.1002/stem.190 · Cited by 279
Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis
Marcelin, G., Silveira, A. L. M., Martins, L. B., Ferreira, A. V. M., & Clément, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129192 · Cited by 275
“Thus, the phenotype of PAFR–/– mice, similarly to mice lacking leptin while overexpressing adiponectin (66) or other mouse models (67–69), illustrates the beneficial impact of limiting local inflammation while maintaining storage capacity in the adipose tissue.”
BackgroundMechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B. J., Withers, S. B., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 272
Kadowaki, T., Yamauchi, T., & Kubota, N. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.070 · Cited by 272
“Scherer s group has generated adiponectin-transgenic ob/ob mice that show serum adiponectin levels 2–3-fold higher than ob/ob mice [18].”
BackgroundEndocrine disrupting chemicals and the developmental programming of adipogenesis and obesity
Janesick, A., & Blumberg, B. (2011) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20197 · Cited by 269
“obese (Kim et al., 2007), and that humans whose diabetes is being treated with rosiglitazone (a drug”
BackgroundVisceral fat and metabolic inflammation: the portal theory revisited
Item, F., & Konrad, D. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01035.x · Cited by 265
“In contrast, secretion of adiponectin, which was found to have insulin-sensitizing and anti-inflammatory properties (34-36), is higher from”
BackgroundRole of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
Cusi, K. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.009 · Cited by 266
Emerging Functions of Regulatory T Cells in Tissue Homeostasis
Sharma, A., & Rudra, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00883 · Cited by 262
“Also, obese ob/ob mice which were made transgenic for full-length adiponectin and thus had adiponectin levels equivalent to treatment with a PPARγ agonist, showed uninhibited WAT expansion leading to morbid obesity but improved insulin sensitivity and other metabolic parameters (94) owing to reduced ectopic lipid depo…”
BackgroundKraakman, M. J., Kammoun, H. L., Allen, T. L., Deswaerte, V., Henstridge, D. C., Estevez, E., Matthews, V. B., Neill, B., White, D. A., Murphy, A. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.006 · Cited by 257
“To determine a possible mechanism for the current observation, we first examined serum adiponectin, a peptide hormone known to induce adipose tissue expansion in a manner similar to our observed phenotype (Kim et al., 2007), but this was not different when comparing mice (Figure S1H).”
ResultMechanisms of obesity and related pathologies: The macro‐ and microcirculation of adipose tissue
Rutkowski, J. M., Davis, K. E., & Scherer, P. E. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07303.x · Cited by 253
Self-citationAdiponectin, driver or passenger on the road to insulin sensitivity?
Ye, R., & Scherer, P. E. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.04.001 · Cited by 251
“As a result, they were more obese but metabolically healthy, as evident by improved glucose uptake, fat metabolism, insulin sensitivity, and β cell survival [82].”
BackgroundSelf-citationAdipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics
Yang, A., & Mottillo, E. P. (2020) · Biochemical Journal · doi:10.1042/bcj20190468 · Cited by 246
Han, C. Y., Kargi, A. Y., Omer, M., Chan, C. K., Wabitsch, M., O'Brien, K. D., Wight, T. N., & Chait, A. (2010) · Diabetes · doi:10.2337/db09-0925 · Cited by 247
“Very obese ob/ob mice with modest adiponectin overexpression were insulin sensitive without macrophage accumulation in adipose tissue (37).”
BackgroundRen, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H. R., & Gao, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873699 · Cited by 244
Association of Lipidome Remodeling in the Adipocyte Membrane with Acquired Obesity in Humans
Pietiläinen, K. H., Róg, T., Seppänen-Laakso, T., Virtue, S., Gopalacharyulu, P., Tang, J., Rodriguez-Cuenca, S., Maciejewski, A., Naukkarinen, J., Ruskeepää, A.-L., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000623 · Cited by 244
“The opposite experimental paradigm, increasing the capacity of adipose tissue expansion by overexpressing adiponectin in white adipose tissue of ob/ob mice (the AdTG-ob/ob mouse), led to a considerably improved metabolic profile as compared to ob/ob mouse [6].”
BackgroundAdipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
Adolph, T., Grander, C., Grabherr, F., & Tilg, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081649 · Cited by 240
“Probably the most compelling evidence for a predominant role of this mediator in obesity and related disorders has been derived from studies generating adipose tissue-specific adiponectin transgenic animals [27].”
BackgroundSexual differences in the control of energy homeostasis
Shi, H., Seeley, R. J., & Clegg, D. J. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.03.004 · Cited by 242
“When obese ob/ob mice are engineered to overexpress adiponectin in adipose tissue, there is a massive increase in subcutaneous fat, and this is associated with improved insulin sensitivity and decreased glucose and insulin levels, increased lipid clearance, improved diacylglycerol levels and fully functional healthy p…”
BackgroundSwarbrick, M. M., & Havel, P. J. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0029 · Cited by 238
“219 As discussed by Behre, 218 in starvation the presence of high adiponectin concentrations in concert with reduced insulin-stimulated glucose uptake.”
Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance
Kim, A. Y., Park, Y. J., Pan, X., Shin, K. C., Kwak, S.-H., Bassas, A. F., Sallam, R. M., Park, K. S., Alfadda, A. A., Xu, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms8585 · Cited by 233
Self-citationKoliwad, S. K., Streeper, R. S., Monetti, M., Cornelissen, I., Chan, L., Terayama, K., Naylor, S., Rao, M., Hubbard, B., & Farese, R. V. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36066 · Cited by 233
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.
van Greevenbroek, M. M. J., Schalkwijk, C., & Stehouwer, C. D. A. (2013) · PubMed · Cited by 290
Chronic Alcohol Exposure Stimulates Adipose Tissue Lipolysis in Mice
Zhong, W., Zhao, Y., Tang, Y., Wei, X., Shi, X., Sun, W., Sun, X., Yin, X., Sun, X., Kim, S., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.017 · Cited by 226
Chen, J., Hui, S. T., Couto, F. M., Mungrue, I. N., Davis, D. B., Attie, A. D., Lusis, A. J., Davis, R. A., & Shalev, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-111690 · Cited by 225
Adipocyte metabolism and obesity
Attie, A. D., & Scherer, P. E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800057-jlr200 · Cited by 225
Self-citationRole of visceral adipose tissue in aging
Huffman, D. M., & Barzilai, N. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.01.008 · Cited by 220
“[47] hypothesized that a major link between obesity and insulin resistance is due to a limited ability to expand SC adipose tissue leading to the expansion of other fat depots and ectopic fat deposition in skeletal muscle and liver.”
BackgroundAdipose tissue plasticity from WAT to BAT and in between
Lee, Y.-H., Mottillo, E. P., & Granneman, J. G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.011 · Cited by 216
Causes and mechanisms of adipocyte enlargement and adipose expansion
Haczeyni, F., Bell‐Anderson, K. S., & Farrell, G. C. (2018) · Obesity Reviews · doi:10.1111/obr.12646 · Cited by 217
“In this study, adiponectinoverexpressing obese Ad-Tg ob/ob mice showed increased adipogenic capacity and an increased proportion of small healthy adipocytes in visceralWAT, aswell as higher systemic insulin sensitivity and glucose tolerance (149).”
BackgroundLipodystrophy: metabolic insights from a rare disorder
Huang-Doran, I., Sleigh, A., Rochford, J. J., O'Rahilly, S., & Savage, D. B. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0272 · Cited by 215
“When crossed with ob/ob mice, these mice become even more obese than standard ob/ob mice and yet manifest significantly improved metabolic homeostasis, suggesting that if adipose tissue can expand to accommodate surplus calories, insulin resistance can be ameliorated (Kim et al. 2007).”
BackgroundAdipose tissue angiogenesis: Impact on obesity and type-2 diabetes
Corvera, S., & Gealekman, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.003 · Cited by 213
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
Shetty, S., Kusminski, C. M., & Scherer, P. E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.004 · Cited by 212
Self-citationWhite adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 209
“excess fat 12,31,32 .”
Mancuso, P. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00781.2009 · Cited by 208
Adipose tissue: between the extremes
Vegiopoulos, A., Rohm, M., & Herzig, S. (2017) · The EMBO Journal · doi:10.15252/embj.201696206 · Cited by 209
“In addition, adipose tissue expansion by increased adiponectin levels improved metabolic health in leptin-deficient obese ob/ob mice (Kim et al , 2007).”
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
Bartelt, A., Widenmaier, S. B., Schlein, C., Johann, K., Goncalves, R. L. S., Eguchi, K., Fischer, A. W., Parlakgül, G., Snyder, N. A., Nguyen, T. B., et al. (2018) · Nature Medicine · doi:10.1038/nm.4481 · Cited by 208
Dalmas, E., Toubal, A., Alzaid, F., Blazek, K., Eames, H. L., Lebozec, K., Pini, M., Hainault, I., Montastier, E., Denis, R. G. P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3829 · Cited by 205
Adipocyte metrnl antagonizes insulin resistance through PPARγ signaling
Li, Z.-Y., Song, J., Zheng, S.-L., Fan, M.-B., Guan, Y.-F., Qu, Y., Xu, J., Wang, P., & Miao, C.-Y. (2015) · Diabetes · doi:10.2337/db15-0274 · Cited by 203
“Improved adipose tissue function and expandability in parallel with adipose remodeling can remedy metabolic complications (36).”
BackgroundBeyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis†
Maher, J. J., Leon, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 203
Adipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 192
“Moreover, serum levels of adiponectin can be used to predict the health of adipose tissue 70 , and targeting this pathway has the potential to improve the management of inflammatory and metabolic disorders in humans.”
Immunologic and endocrine functions of adipose tissue: implications for kidney disease
Zhu, Q., & Scherer, P. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.157 · Cited by 200
Self-citationThe Impact of Oxidative Stress on Adipose Tissue Energy Balance
Masschelin, P. M., Cox, A. R., Chernis, N., & Hartig, S. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01638 · Cited by 199
Obesity Paradox and Cardiorespiratory Fitness in 12,417 Male Veterans Aged 40 to 70 Years
McAuley, P. A., Kokkinos, P. F., Oliveira, R. B., Emerson, B. T., & Myers, J. N. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0562 · Cited by 199
Systemic Fate of the Adipocyte-Derived Factor Adiponectin
Halberg, N., Schraw, T. D., Wang, Z. V., Kim, J.-Y., Yi, J., Hamilton, M. P., Luby-Phelps, K., & Scherer, P. E. (2009) · Diabetes · doi:10.2337/db08-1750 · Cited by 197
“It acutely lowers blood glucose levels through suppression of hepatic glucose levels and chronically has potent insulin sensitizing effects through reduction of hepatic lipids (1-3).”
BackgroundSelf-citationPaniagua, J. A. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i19.483 · Cited by 197
Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome
Carobbio, S., Pellegrinelli, V., & Vidal-Puig, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_7 · Cited by 194
SPARC: a key player in the pathologies associated with obesity and diabetes
Kos, K., & Wilding, J. P. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.18 · Cited by 192
“This link has been experimentally demonstrated by overexpressing adiponectin in leptin-deficient ob/ob mice, a model of T2DM, which led to an increase in subcutaneous adipose tissue stores and, despite increased weight, improved insulin sensitivity”
BackgroundAdipocyte CREB Promotes Insulin Resistance in Obesity
Qi, L., Saberi, M., Zmuda, E., Wang, Y., Altarejos, J., Zhang, X., Dentin, R., Hedrick, S., Bandyopadhyay, G., Hai, T., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.006 · Cited by 190
“, 2006), while over-expression of adiponectin enhances it, in part through effects on hepatic glucose production (Berg et al., 2001; Combs et al., 2001; Kim et al., 2007; Satoh et al., 2005; Yamauchi et al., 2002b).”
BackgroundAdipose tissue and metabolic syndrome: too much, too little or neither
Grundy, S. M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12519 · Cited by 187
Tardif, N., Salles, J., Guillet, C., Tordjman, J., Reggio, S., Landrier, J., Giraudet, C., Patrac, V., Bertrand‐Michel, J., Migne, C., et al. (2014) · Aging Cell · doi:10.1111/acel.12263 · Cited by 186
“Inversely, promoting the storage of fat preferentially in adipose tissue with adiponectin transgenic ob/ob mice or peroxisome proliferator-activated receptor gamma (PPARgamma) agonist treatment improved insulin sensitivity (Kim et al., 2007).”
BackgroundImmune and inflammatory pathways in NASH
Ganz, M., & Szabo, G. (2013) · Hepatology International · doi:10.1007/s12072-013-9468-6 · Cited by 184
“the obese phenotype, suggesting that adiponectin plays a critical role in preventing both local and systemic inflammation [95].”
BackgroundBrd2 disruption in mice causes severe obesity without Type 2 diabetes
Wang, F., Liu, H., Blanton, W. P., Belkina, A., Lebrasseur, N. K., & Denis, G. V. (2010) · Biochemical Journal · doi:10.1042/bj20090928 · Cited by 185
“This serum adiponectin concentration matches the hyperadiponectinaemia of male adiponectin transgenic mice [49]; approximately half this concentration is sufficient to rescue ob/ob mice from Type 2 diabetes [38].”
BackgroundInfluentialLipid droplet proteins and metabolic diseases
Xu, S., Zhang, X., & Liu, P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.019 · Cited by 184
Adipocytokines and Insulin Resistance
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2009) · Diabetes Care · doi:10.2337/dc09-s340 · Cited by 184
“Mice overexpressing adiponectin showed normalized glucose and partial amelioration of insulin resistance and diabetes and a reduction in macrophage infiltration in adipose tissue and systemic inflammation (31).”
Targeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
“(138) showed that ectopic fat storage and insulin resistance can be ameliorated when adipose tissue mass can properly expand to accommodate excess calories.”
BackgroundKim, S.-J., Nian, C., Karunakaran, S., Clee, S. M., Isales, C. M., & McIntosh, C. H. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040156 · Cited by 182
“In a recent study, it was demonstrated that overexpression of adiponectin in mice on an ob/ob genetic background resulted in greater obesity, compared to non-transgenic animals, but with marked improvements in both glucose tolerance and insulin resistance, as well as reduced circulating TG and hepatic steatosis [31].”
BackgroundMathew, H., Farr, O. M., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.019 · Cited by 182
“For instance, adiponectin transgenic mice on an ob/ob background become obese on a normal diet but remain insulin sensitive and show fewer inflammatory markers without liver steatosis [39].”
Hubal, M. J., Nadler, E. P., Ferrante, S. C., Barberio, M. D., Suh, J., Wang, J., Dohm, G. L., Pories, W. J., Mietus‐Snyder, M., & Freishtat, R. J. (2017) · Obesity · doi:10.1002/oby.21709 · Cited by 181
“resistance and metabolic dysregulation, exerting effects via mechanisms such as releasing proinflammatory cytokines into circulation (1-4).”
BackgroundReappraisal of GIP Pharmacology for Metabolic Diseases
Finan, B., Müller, T. D., Clemmensen, C., Perez-Tilve, D., DiMarchi, R. D., & Tschöp, M. H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.005 · Cited by 180
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
Larter, C. Z., Chitturi, S., Heydet, D., & Farrell, G. C. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06253.x · Cited by 180
Chan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 177
“and offer protection against vascular dysfunction commonly associated with COPD andMetS (Kim et al., 2007).”
BackgroundMiller, R. A., Chu, Q., Le Lay, J., Scherer, P. E., Ahima, R. S., Kaestner, K. H., Foretz, M., Viollet, B., & Birnbaum, M. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45942 · Cited by 179
“The role has been further established in studies showing that the reversal of decreased serum adiponectin levels in ob/ob mice through transgenic expression can dramatically improve their metabolic profile (15).”
BackgroundSelf-citationFructose: A Key Factor in the Development of Metabolic Syndrome and Hypertension
Khitan, Z., & Kim, D. H. (2013) · Journal of Nutrition and Metabolism · doi:10.1155/2013/682673 · Cited by 180
“This was criticized on the basis of fructose causing weight gain by altering appetite resulting in increased food intake, by inducing leptin resistance and by a direct effect on the brain indicating that isocaloric trials do not show a difference in weight gain between groups.”
BackgroundLi, H., Wu, G., Fang, Q., Zhang, M., Hui, X., Sheng, B., Wu, L., Bao, Y., Li, P., Xu, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02677-9 · Cited by 178
Self-citationMedrikova, D., Jilkova, Z. M., Bardova, K., Janovska, P., Rossmeisl, M., & Kopecky, J. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.87 · Cited by 178
MECHANISMS IN ENDOCRINOLOGY: Are metabolically healthy obese individuals really healthy?
Blüher, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0540 · Cited by 177
Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease
Kim, D., Chung, G. E., Kwak, M.-S., Seo, H. B., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Lee, H.-S., & Kim, C. Y. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.024 · Cited by 174
Inflammation during obesity is not all bad: evidence from animal and human studies
Ye, J., & McGuinness, O. P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2012 · Cited by 174
Holland, W. L., Xia, J. Y., Johnson, J. A., Sun, K., Pearson, M. J., Sharma, A. X., Quittner-Strom, E., Tippetts, T. S., Gordillo, R., & Scherer, P. E. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.01.002 · Cited by 174
“Studies with genetic manipulation of adiponectin receptors show similar trends as adiponectin itself, and human single nucleotide polymorphisms in AdipoR1 or AdipoR2 are significantly associated with hepatic triglyceride accumulation [9,22] and enhanced risk for cirrhosis [15].”
BackgroundSelf-citationThe role of JAK–STAT signaling in adipose tissue function
Richard, A. J., & Stephens, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.030 · Cited by 172
“Other examples [41,43], including these findings with the GM-CSF knockout mice [42], seem to rule out increased adipocyte size as the causative factor in the relationship between AT dysfunction and insulin resistance.”
ResultAdiponectin Promotes Functional Recovery after Podocyte Ablation
Rutkowski, J. M., Wang, Z. V., Park, A. S. D., Zhang, J., Zhang, D., Hu, M. C., Moe, O. W., Susztak, K., & Scherer, P. E. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040414 · Cited by 172
Self-citationAdiponectin in inflammatory and immune-mediated diseases
Fantuzzi, G. (2013) · Cytokine · doi:10.1016/j.cyto.2013.06.317 · Cited by 171
Distribution of body fat and risk of coronary heart disease in men and women
Canoy, D. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328313133a · Cited by 171
Adiponectin and energy homeostasis
Lee, B., & Shao, J. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9283-3 · Cited by 171
“The starvation hormone characteristics of adiponectin have been observed in animal studies [61, 62].”
BackgroundInfluentialA liver stress-endocrine nexus promotes metabolic integrity during dietary protein dilution
Maida, A., Zota, A., Sjøberg, K. A., Schumacher, J., Sijmonsma, T. P., Pfenninger, A., Christensen, M. M., Gantert, T., Fuhrmeister, J., Rothermel, U., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85946 · Cited by 170
Nicolai, A., Li, M., Kim, D. H., Peterson, S. J., Vanella, L., Positano, V., Gastaldelli, A., Rezzani, R., Rodella, L. F., Drummond, G., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.124701 · Cited by 170
The Importance of Breast Adipose Tissue in Breast Cancer
Kothari, C., Diorio, C., & Durocher, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165760 · Cited by 170
Metabolically healthy and unhealthy obese – the 2013 Stock Conference report
Samocha‐Bonet, D., Dixit, V. D., Kahn, C. R., Leibel, R. L., Lin, X., Nieuwdorp, M., Pietiläinen, K. H., Rabasa‐Lhoret, R., Roden, M., Scherer, P. E., et al. (2014) · Obesity Reviews · doi:10.1111/obr.12199 · Cited by 169
“As a result, the Scherer lab showed that systemic insulin sensitivity improved, that is an overall phenotype reminiscent of chronic exposure to pharmacological doses of peroxisome proliferator-activated receptor gamma agonists (56).”
BackgroundSelf-citation‘Metabolically healthy obesity’: Origins and implications
Denis, G. V., & Obin, M. S. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.004 · Cited by 169
“Adiponectin transgenic mice on an ob/ob background (AdTg) have 2- to 3-fold higher levels of circulating adiponectin than ob/ob controls (Kim et al., 2007).”
Background
Metadata
- Authors
- Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., Jelicks, L. A., Mehler, M. F., Hui, D. Y., Deshaies, Y., Shulman, G. I., Schwartz, G. J., & Scherer, P. E.
- Affiliations
- Université Laval (CA)
- Albert Einstein College of Medicine (US)
- University of Cincinnati (US)
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Scherer, Philipp E.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-09-04
- Volume
- 117
- Issue
- 9
- Pages
- 2621-2637
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1950456
- OpenAlex
- W2159346623
- Cited by
- 1,310
- References
- 61
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 67 · 2021: 66 · 2020: 57 · 2019: 64 · 2018: 67 · 2017: 73 · 2016: 62 · 2015: 76 · 2014: 96 · 2013: 115 · 2012: 88
- FWCI
- 58.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- American Heart Association
- National Institutes of Health (DK 59630, DK026687)
- Albert Einstein College of Medicine, Yeshiva University
- National Cancer Institute (R01CA112023)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 59630, R01 DK 55758, R01DK040936, U24DK059635, R01DK055758, DK026687, R01DK066618, U24DK059630, R24DK071030, R21DK075887, R24-DK071030-01, P30DK026687)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- adiponectin, leptin deficiency, ob/ob mice, morbid obesity, insulin resistance, adipose tissue expansion, ectopic fat deposition, PPARγ target genes, macrophage infiltration, systemic inflammation, triglyceride storage, beta-cell failure, metabolic profile
- MeSH terms
- Adipose Tissue, Animals, Animal Feed, Diglycerides, Fats, Gene Expression Regulation, Immunohistochemistry, Insulin, Insulin Resistance, Islets of Langerhans, Lipoproteins, Liver, Macrophages, Mice, Transgenic, Obesity, Organ Size, Phenotype, Triglycerides, Leptin, PPAR gamma, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.